Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingning Wan is a traditional Chinese medicine (TCM) formulation manufactured by Zhejiang Tianyitang Pharmaceutical. It is primarily indicated for clearing internal heat, detoxification, and relieving constipation. The formulation typically features Rhubarb (Dahuang) as its principal ingredient, often processed to moderate its purgative effects while enhancing its ability to clear heat from the blood. It is commonly used to treat symptoms associated with 'internal fire,' such as constipation, sore throat, mouth ulcers, and swollen gums. As a traditional herbal product, its therapeutic effects are attributed to the synergistic action of its multiple botanical constituents rather than a single molecular target. It is an approved and commercially available product in the Chinese market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingning Wan.